Featured Vendors (1 - 4 of 8)
Organizations in the complex and rapidly changing field of biotechnology need to focus exclusively on improving their core business areas. Smaller companies in this realm often chose to specialize in particular areas of biotechnology but lack the resources to access genomics technologies. In this case, Analome steps in to aid companies in focusing solely on their area of interest by handling essential projects that would otherwise require large-scale investments. The company’s extensive experience makes it highly efficient in leveraging key resources to create accurate, cost-effective solutions for customers. David Kovalic, Ph.D., President of Analome, speaks about how his company is making a difference in the genomics landscape.
What are the current trends in the areas of bioinformatics and genomics? How does Analome plan to influence these trends?
A variety of new scientific applications that allow targeted genome editing are opening new scientific horizons, like the prospect of curing inherited diseases, are constantly coming to light. These technological advancements were considered impossible until recently; Analome is experienced in this area and currently assisting multiple clients with these technologies. Game-changing genomic technologies such as ultra-long sequencing have opened up new possibilities in the field of R&D. Analome’s ability to offer access to genomics technologies in a rapid, methodical, and focused manner proves invaluable to its customers.
The changing role of new IT trends in genomics and bioinformatics can be best observed in the usage of cloud-based systems, which allow the flexible utilization of resources to meet client requirements with efficient solutions. The bioinformatics industry has also benefited from the advanced insights into data provided by analytics. The use of AI and multi-omics approaches enable computers to go through large data sets to understand the prime examples and enhance our knowledge of various diseases. Genomics-based personalized medicine has become a reality and is improving patient health on a daily basis.
Analome offers dynamic solutions by operating at the nexus of these changing trends.
Tell us about Analome. How do its product offerings benefit customers?
Using our extensive experience in the bioinformatics sector, Analome was created to be a provider of custom genomic services to the biotech industry.
Analome’s ability to offer access to genomics technologies in a rapid, methodical, and focused manner proves invaluable to customers
Our specialization in this industry led us to offer tailor-made turnkey genomics solutions to our clients to get their projects completed more successfully, faster and at a lower cost. Our company offers a wide range of facilities and services, including strategic consulting and project management, as well as project execution. Analome accelerates scientific discovery with experienced genomics and bioinformatics; we assist scientists in moving from ideas to results and by turning customer data into knowledge.
We take a variety of projects in the biotech industry and enable customer access to world-class genomics data and analytics, which can be added to their technology platform. Collaborating with the clients, we leverage their genomic data in driving the core of their business and empower them to make confident business decisions. Our expertise in bioinformatics and genomics allows us help clients capture key IP in their area of interest. This ensures their business security and aids them to complete genomics jobs faster, more cost-effectively to be ahead of competitors.
While bigger players in the industry seek highly specified services from our range of offerings, smaller organizations steer towards end-to-end solutions that cover all their genomics requirements.
How does Analome differentiate itself from other players in the market?
Besides our rich expertise, our ability to offer fast, efficient, and cost-effective solutions customized to fit individual client specifications makes us second to none. Analome forms partnerships with customer businesses and provides them with dedicated personal assistants. Our focus on value co-creation enables us to support clients with consistent engagement and understanding. The personalized service provided by Analome caters to each business partner on a case-by-case basis, leading to the creation of a unique offering whereby we share close ties with our customers and fully understand their needs.
As our informatics capability was built with information security and regulatory compliance in mind, our clients can execute their projects with confidence in all data compliance aspects. We assist customers in ensuring that data submitted to global regulatory organizations meet their mandates. Analome’s focus is unmatched when it comes to delivering accurate analysis of underlying genomic data requiring submission. Our skills allow clients to complete the final late-stage regulation-based hurdles and accelerate time to market.
Can you share a customer success story with us to bring out the effectiveness of your solution?
A customer with no prior experience in the agricultural sector approached Analome to build a CRISPR-based technology to advance the traits of their agricultural biotech product. We partnered with them to build a complete CRISPR R&D system from scratch. Since then, their product development has been driven forward with multiple beneficial traits while simultaneously capturing key IP.
Where do you see Analome in the future?
Our mission is to consistently emphasize and meet the needs of our clients. Watching these companies grow, create jobs and enhance their communities, is rewarding. Over the past few years, we have realized that our success is: the success of our customers. Analome’s aim is to continue growing while providing the newest and best possible biotech solutions for our clients.